US Broker Ratings

AxoGen, Inc. (AXGN) Investor Outlook: Exploring a Promising 124% Potential Upside

AxoGen, Inc. (NASDAQ: AXGN), a key player in the healthcare sector specializing in medical devices, is capturing investor attention with its promising potential upside of 124.12%. With a market capitalization..

Savara, Inc. (SVRA) Stock Analysis: A Biotech Prospect with a 271% Potential Upside

For investors eyeing the biotechnology sector, Savara, Inc. (NASDAQ: SVRA) represents a compelling opportunity, particularly for those interested in companies focusing on rare respiratory diseases. With a market capitalization of..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating Challenges for Potential Growth in Healthcare

Enhabit, Inc. (EHAB), a prominent player in the healthcare sector, particularly in the medical care facilities industry, provides essential home health and hospice services across the United States. With a..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Biotechnology Innovator with a Stunning 221% Potential Upside

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, is making waves in the biotechnology sector. With a market capitalization of $418.34 million, the company is..

Owens & Minor, Inc. (OMI) Stock Analysis: Navigating a 50% Potential Upside in the Healthcare Sector

Owens & Minor, Inc. (NYSE: OMI), a venerable name in the healthcare sector with roots dating back to 1882, presents a complex yet intriguing case for investors. With a current..

Septerna, Inc. (SEPN) Stock Analysis: Unpacking the 140% Potential Upside in the Biotechnology Space

Septerna, Inc. (NASDAQ: SEPN) is drawing significant attention from the investor community, given its promising potential upside of 140.03%. As a clinical-stage biotechnology company, Septerna offers a unique value proposition..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Uncovering a 41% Potential Upside in the Healthcare Sector

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) is captivating investors’ attention with a notable potential upside of over 41%, according to recent analyst ratings. As a specialty pharmaceutical company focused on innovative..

Inventiva S.A. (IVA) Stock Analysis: Unveiling a 221% Potential Upside in Biotech

Inventiva S.A. (NASDAQ: IVA) is gaining attention among investors due to its promising biopharmaceutical pipeline and a staggering potential upside of over 221%, according to the latest analyst ratings. As..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: A Biopharma Player with 140% Upside Potential

For investors seeking a compelling opportunity in the healthcare sector, Akebia Therapeutics, Inc. (NASDAQ: AKBA) stands out with its remarkable potential for growth. This Cambridge, Massachusetts-based biopharmaceutical company is making..

Delcath Systems, Inc. (DCTH) Stock Analysis: Unpacking a 41% Potential Upside in the Medical Devices Sector

Delcath Systems, Inc. (NASDAQ: DCTH), a burgeoning name in the healthcare sector, particularly in medical devices, is drawing investor attention with its impressive 41.14% potential upside. With a current market..

Xencor, Inc. (XNCR) Stock Analysis: Exploring a Biotechnology Innovator with 264.58% Potential Upside

Xencor, Inc. (NASDAQ: XNCR) is making waves in the biotechnology sector with its innovative approach to the discovery and development of engineered monoclonal antibodies, targeting a range of diseases from..

Maravai LifeSciences Holdings (MRVI) Investor Outlook: Insights into Nearly 98% Potential Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a prominent player in the biotechnology industry, focusing on nucleic acid production and biologics safety testing. With its headquarters in San Diego, California,..

Auna SA (AUNA) Stock Analysis: Strong Buy Ratings Signal Nearly 95% Upside Potential

For investors scouting the healthcare sector, Auna SA (AUNA), a Luxembourg-based healthcare service provider, presents a compelling opportunity. With operations spanning hospitals and clinics in Mexico, Peru, and Colombia, AUNA..

Semler Scientific, Inc. (SMLR) Stock Analysis: Navigating the Waves of Revenue Decline and Market Potential

Investors eyeing the healthcare sector may find Semler Scientific, Inc. (NASDAQ: SMLR) an intriguing proposition, especially given its niche focus on medical devices for enhancing clinical effectiveness. Despite a challenging..

Sonida Senior Living, Inc. (SNDA): Investor Outlook with 6.47% Potential Upside

Sonida Senior Living, Inc. (SNDA), a key player in the Healthcare sector under the Medical Care Facilities industry, presents a compelling case for individual investors seeking exposure to the burgeoning..

InnovAge Holding Corp. (INNV) Stock Analysis: Exploring a 23.46% Potential Upside for Investors

InnovAge Holding Corp. (NASDAQ: INNV), a notable player in the healthcare sector, primarily focuses on providing comprehensive medical and ancillary services for the elderly. With its unique Program of All-Inclusive..

Amylyx Pharmaceuticals, Inc. (AMLX) Investor Outlook: Exploring a Potential 120% Upside in Biotechnology

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a clinical-stage biotech firm based in Cambridge, Massachusetts, offers an intriguing opportunity for investors looking to capitalize on the burgeoning healthcare sector. Specializing in the..

Geron Corporation (GERN) Stock Analysis: Exploring a 149% Potential Upside in Biotech

Geron Corporation (NASDAQ: GERN), a key player in the biotechnology sector, has been capturing investor attention with its promising outlook and significant potential upside. Currently trading at $1.48 per share,..

Oculis Holding AG (OCS) Stock Analysis: A Biotech Gem with 69.9% Potential Upside

For investors seeking promising opportunities in the biotech sector, Oculis Holding AG (OCS) is a name that stands out. The Swiss-based clinical-stage biopharmaceutical company is gaining attention for its innovative..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds